Clinical utility of repurposing a short course of hepatitis C drugs for COVID19. A randomized controlled study

Mostafa Yakoot, Basem Eysa, Essam Gouda, Sherine A Helmy, Mahmoud R Elsayed, Ola Elrouby, Amal Mohamed, Ehab Reyad, Mohamed M Fawzi, Safaa Elmandouh, Wessam Abdellatif, Ahmed A Zidan, Abd-Elmoniem Adel, Mohamed Hassany
doi: https://doi.org/10.1101/2022.07.18.22277477

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

Back to top
Posted July 18, 2022.
Download PDF
Data/Code
Email
Clinical utility of repurposing a short course of hepatitis C drugs for COVID19. A randomized controlled study
Mostafa Yakoot, Basem Eysa, Essam Gouda, Sherine A Helmy, Mahmoud R Elsayed, Ola Elrouby, Amal Mohamed, Ehab Reyad, Mohamed M Fawzi, Safaa Elmandouh, Wessam Abdellatif, Ahmed A Zidan, Abd-Elmoniem Adel, Mohamed Hassany
medRxiv 2022.07.18.22277477; doi: https://doi.org/10.1101/2022.07.18.22277477
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area